 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/09/2017 |
$1.33 |
$1.40 |
$1.30 |
$1.34 |
217.10K | | 11/10/2017 |
$1.34 |
$1.42 |
$1.30 |
$1.39 |
530.10K | | 11/13/2017 |
$1.39 |
$1.48 |
$1.39 |
$1.44 |
236.10K | | 11/14/2017 |
$1.43 |
$1.44 |
$1.35 |
$1.40 |
116.00K | | 11/15/2017 |
$1.40 |
$1.64 |
$1.40 |
$1.46 |
1.11M |
|
|
| Arcturus Therapeutics is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary oral drug candidate, MDX, to treat ADHD and other cognitive dysfunctions including Fragile X Syndrome. The most common available treatments for ADHD are stimulants that increase the brain chemicals dopamine and norepinephrine. Stimulants have significant side effects, and are classified as controlled substances which have significant potential for misuse, abuse and addiction. MDX is not a stimulant, and works with a different mechanism of action. MDX is a proprietary, combined rapid onset release formulation of the chemical Pyridoxine Pyroglutamate. | |
|
ADHD (ADHD) has the following price history information. Looking back at ADHD historical stock prices for the last five trading days, on November 09, 2017, ADHD opened at $1.33, traded as high as $1.40 and as low as $1.30, and closed at $1.34. Trading volume was a total of 217.10K shares. On November 10, 2017, ADHD opened at $1.34, traded as high as $1.42 and as low as $1.30, and closed at $1.39. Trading volume was a total of 530.10K shares. On November 13, 2017, ADHD opened at $1.39, traded as high as $1.48 and as low as $1.39, and closed at $1.44. Trading volume was a total of 236.10K shares. On November 14, 2017, ADHD opened at $1.43, traded as high as $1.44 and as low as $1.35, and closed at $1.40. Trading volume was a total of 116.00K shares. On November 15, 2017, ADHD opened at $1.40, traded as high as $1.64 and as low as $1.40, and closed at $1.46. Trading volume was a total of 1.11M shares.
ADHD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ADHD shares, starting with a $10,000 purchase of ADHD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
11/15/2017 |
|
| Start price/share: |
$17.84 |
|
| End price/share: |
$1.46 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-91.82% |
|
| Average Annual Total Return: |
-50.40% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$818.30 |
|
| Years: |
3.57 |
|
|
|
| Date |
Close |
| 11/09/2017 | $1.34 | | 11/10/2017 | $1.39 | | 11/13/2017 | $1.44 | | 11/14/2017 | $1.40 | | 11/15/2017 | $1.46 |
|
|
Free ADHD Email Alerts:
